Practical Mass Spectrometry Upgrade for Identifying Fragile Protein Modifications by ECD

通过 ECD 识别脆性蛋白质修饰的实用质谱升级

基本信息

  • 批准号:
    9253957
  • 负责人:
  • 金额:
    $ 22.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

The speed, resolution and high mass accuracy of modern mass spectrometers have revolutionized proteomics, particularly for determining fragile post-translational modifications that control most cellular processes. Accurate identification and quantitation of phosphorylation sites remain a major challenge in proteomics. The key weakness with mass spectrometry for phospho-proteomics lies in the methods used to induce fragmentation, because phosphoryl bonds are among the most labile chemical bonds in proteins and are lost in complex ways by current collision-based fragmentation approaches. An alternative fragmentation methodology called electron capture dissociation (ECD) is well established to produce exceptional spectra of phosphopeptides, but is currently feasible only in expensive FTICR mass spectrometers. The fundamental limitation to ECD is providing enough low-energy electrons to efficiently fragment peptides. We have two issued patents protecting a new technology enabling a practical ECD cell that uses carefully sculpted magnetic fields to confine electrons. The ECD cell is only two centimeters in length and can be readily incorporated into virtually any mass spectrometer. The major factor limiting adaption with our ECD cell is that the efficiency is limited to 5-10% for doubly charged phosphopeptides. This raise concerns about the loss of sensitivity for low abundance peptides. However, peptides now fly just once through the cell. Our Phase-I proposes to increase this efficiency by reflecting ions to make multiple passages through the ECD cell. For this purpose, we will focus on Orbitrap mass spectrometers, which have become the most widely used instruments for proteomics. Their unique design allows integration of the ECD cell without changing any component in the Orbitrap itself. The feasibility question to be answered in Phase-I is: how to best incorporate the ECD cell to pass peptides and proteins through the cell multiple times to increase fragmentation efficiency? The challenge is to avoid losing sensitivity because of peptide ions scattering as they are reflected. In Phase-II, we will work with early- adopters to validate the cell for quantifying post-translational modifications by both top-down and bottom-up proteomic approaches. Supporting letters are included from the discoverer of ECD, the inventor of the Orbitrap, and two internationally known leaders of proteomics. Phase-III will be to provide cost-effective upgrade kits for the thousands of Orbitraps currently in operation. As the technology wins acceptance, our company will develop new generations of mass spectrometers capitalizing on the additional information provided by ECD. The adoption of our technology for a modest cost will accelerate the ability of many NIH investigators to probe disease mechanisms as well as identify diagnostic and therapeutic biomarkers with increased accuracy, greater speed and fewer mistakes.
现代质谱仪的速度、分辨率和高质量准确度已经彻底改变了蛋白质组学, 特别是用于确定控制大多数细胞过程的脆弱的翻译后修饰。 磷酸化位点的准确鉴定和定量仍然是蛋白质组学中的一个主要挑战。 质谱用于磷酸化蛋白质组学的关键弱点在于用于诱导的方法 断裂,因为磷酰基键是蛋白质中最不稳定的化学键之一, 通过目前基于碰撞的碎片化方法以复杂的方式。另一种分裂 一种称为电子捕获解离(ECD)的方法已经建立,可以产生特殊的光谱, 磷酸肽,但目前仅在昂贵的FTICR质谱仪中可行。根本 对ECD的限制是提供足够的低能电子以有效地使肽片段化。我们有两 已发布专利,保护一项新技术,该技术使一种实用的ECD电池能够使用精心雕刻的磁性材料, 场来限制电子。ECD电池的长度仅为两厘米,并且可以容易地并入到电池中。 几乎所有的质谱仪限制我们的ECD细胞适应的主要因素是效率 限制为5-10%的双电荷磷酸肽。这引起了人们对低灵敏度的担忧。 丰度肽。然而,肽现在只在细胞中飞行一次。我们的第一阶段建议增加 通过反射离子使其多次通过ECD池来提高这种效率。为此,我们将 Orbitrap质谱仪已成为蛋白质组学中使用最广泛的仪器。 其独特的设计允许在不改变Orbitrap本身任何组件的情况下集成ECD单元。 在第一阶段要回答的可行性问题是:如何最好地纳入ECD细胞通过肽 和蛋白质通过细胞多次,以增加破碎效率?挑战在于避免 由于肽离子在反射时散射而失去灵敏度。在第二阶段,我们将与早期- 采用者通过自上而下和自下而上两种方式来验证用于量化翻译后修饰的细胞 蛋白质组学方法支持信包括从发现者的幼儿发展,发明者的 Orbitrap和两位国际知名的蛋白质组学领导者。第三阶段将提供具有成本效益的 升级套件,用于目前运行的数千个轨道器。随着技术赢得认可, 公司将开发新一代的质谱仪利用额外的信息 由ECD提供。以适度的成本采用我们的技术将加速许多NIH 研究人员探索疾病机制以及确定诊断和治疗生物标志物, 提高准确性、加快速度并减少错误。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improved Protein and PTM Characterization with a Practical Electron-Based Fragmentation on Q-TOF Instruments.
改善了基于Q-TOF仪器的实用电子碎片,改善了蛋白质和PTM表征。
  • DOI:
    10.1021/jasms.0c00482
  • 发表时间:
    2021-08-04
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Beckman JS;Voinov VG;Hare M;Sturgeon D;Vasil'ev Y;Oppenheimer D;Shaw JB;Wu S;Glaskin R;Klein C;Schwarzer C;Stafford G
  • 通讯作者:
    Stafford G
Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry Using Electron Capture Dissociation and Ultraviolet Photodissociation.
  • DOI:
    10.1021/acs.analchem.9b03129
  • 发表时间:
    2020-01-07
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Shaw JB;Liu W;Vasil Ev YV;Bracken CC;Malhan N;Guthals A;Beckman JS;Voinov VG
  • 通讯作者:
    Voinov VG
Top-Down Characterization of Denatured Proteins and Native Protein Complexes Using Electron Capture Dissociation Implemented within a Modified Ion Mobility-Mass Spectrometer.
  • DOI:
    10.1021/acs.analchem.9b04763
  • 发表时间:
    2020-03-03
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Williams JP;Morrison LJ;Brown JM;Beckman JS;Voinov VG;Lermyte F
  • 通讯作者:
    Lermyte F
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Valery G. Voinov其他文献

Valery G. Voinov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Valery G. Voinov', 18)}}的其他基金

Real time optimization of electron-based fragmentation for middle and top-down proteomics in mass spectrometry
质谱中中自上而下蛋白质组学基于电子的碎片实时优化
  • 批准号:
    10081127
  • 财政年份:
    2020
  • 资助金额:
    $ 22.5万
  • 项目类别:
Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics
基于双电子的断裂和离子淌度以推进天然自上而下的蛋白质组学
  • 批准号:
    10009626
  • 财政年份:
    2019
  • 资助金额:
    $ 22.5万
  • 项目类别:
Enabling electron-induced fragmentation in tandem mass spectrometry
在串联质谱分析中实现电子诱导碎裂
  • 批准号:
    9346138
  • 财政年份:
    2017
  • 资助金额:
    $ 22.5万
  • 项目类别:
Practical Mass Spectrometer Upgrade for Identifying Fragile Protein Modifications by ECD
用于通过 ECD 识别脆性蛋白质修饰的实用质谱仪升级
  • 批准号:
    9542850
  • 财政年份:
    2017
  • 资助金额:
    $ 22.5万
  • 项目类别:
Enabling electron-induced fragmentation in tandem mass spectrometry
在串联质谱分析中实现电子诱导碎裂
  • 批准号:
    9751318
  • 财政年份:
    2017
  • 资助金额:
    $ 22.5万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.5万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.5万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 22.5万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 22.5万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了